Service de Pneumologie, CHUV
Lausanne, Canton of Vaud, 1011, Switzerland
NCT Number: NCT04729920
With this cross-sectional study of adult subjects with neuromuscular disease in the French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report questionnaires and device data in order to identify the factors that influence the pattern of MI-E use and satisfaction with the treatment. Determining potential barriers to regular long-term home use of MI-E could help in identifying the patients who would benefit most from this therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Lausanne, Canton of Vaud, 1011, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-Invasive airway
download of device (MI-E) data and self-reported satisfaction with the device
Time frame: 12 months, or since treatment initiation (> 3 months)
based on self-reported use
Time frame: 12 months, or since treatment initiation (> 3 months)
based on data downloads
Time frame: 12 months, or since treatment initiation (> 3 months)
Self-report questionnaire
Looking for future studies?
Notify MeCentre Hospitalier Universitaire Vaudois
Other
Predictors of Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Patients: a Cross-sectional Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05227274
Behavior, Health Behavior
Brest, France
View Trial DetailsNCT05479981
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1
Los Angeles, California, United States
View Trial DetailsNCT00720161
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Leuven, Brabant, Belgium
View Trial DetailsNCT06119087
Airway Clearance Impairment, Amyotrophic Lateral Sclerosis
Philadelphia, Pennsylvania, United States
View Trial Details